PCI is a leading provider of integrated pharmaceutical development services to the global healthcare market. With facilities in North America and Europe, PCI supports pharmaceutical and biotech companies with products destined for more than 100 countries around the world. PCI provides services for each stage of the product lifecycle – from early Phase I through commercial launch and long-term supply – and partners with customers to provide key insight and expertise in enabling successful commercialization and bringing lifesaving medications to patients. For more information, go to www.pci.com.

Contact Vendor

Building Robust Supply Chains to Prevent Drug Shortages

Download now to explore the:

Vulnerability of pharma supply chains
Need to increase agility and robustness to prevent drug shortages
Crucial role of updated risk mitigation strategies
Critical importance of accurate forecasting capabilities
Importance of your CDMO’s strategic fit, product value, and performance

11/15/2023

View Content

The Challenges of Scalability in High Potent Manufacturing

High potency is one of pharma’s fastest-growing sectors, with potential opportunities rapidly growing. Download your free roundtable summary to:

Explore the obstacles and opportunities associated with the scalable manufacture of drug products containing high potency APIs (HPAPIs)

Examine the pros and cons of in-house manufacturing versus a contract development and manufacturing organization (CDMO)

Inform your important decision making around moving forward with a successful HPAPI manufacturing strategy

6/8/2023

View Content